Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer

Part of paid clinical trials in Dallas, Texas.

Sponsor
University of Texas Southwestern Medical Center
Study ID
NCT06552000
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • NovoTTF-200T System — DEVICE
    Exposure/Frequency: 150 kHz Route: Transdermal through patented microarray system to the hemithorax affected with cancer, 2-4 week duration, target 18 hours/day (on average)

Study Details

The purpose of this study is to study the clinical and biologic effects of Tumor Treatment Fields (TTFields) in patients undergoing resection of stage I-IIIA Non-Small Cell Lung Cancer (NSCLC). TTField is a non-invasive treatment that uses low-intensity electrical fields to treat cancer. Resection is the medical term for surgically removing part or all of a tissue, structure, or organ.

Key Dates

Start date
Jul 1, 2026
Status verified
Feb 2026
Primary completion
Dec 1, 2029
Completion
Dec 1, 2030

Study Design

Enrollment
18 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Tumor Treatment Fields
    Duration: 2-4 week; target 18 hours/day (on average). Continuous between time of enrollment and date of surgery. Cycle Length: 2-4 weeks

Primary Outcome Measure

Effect of TTF (Tumor-Treating Fields) on Fanconi anemia-related genes. [ Time Frame: approximately 14-28 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Texas Southwestern Medical CenterDallasTexas75390
Ebele Mbanugo, Ed.D, CCRP
[email protected]
214-645-0326
John Waters, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Dallas, TX

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
The University of Texas Southwestern Medical Center· Dallas, TX

Related Studies